Epigenetics in Cystic Fibrosis: Epigenetic Targeting of a Genetic Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|9|976-987

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.9, 2015-01, pp. : 976-987

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting a Genetic Killer: Novel Disease-Modifying Therapies for Cystic Fibrosis

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 4, 2006-01 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Targeting neutrophil elastase in cystic fibrosis

By Kelly Emer   Greene Catherine M   McElvaney Noel G  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 145-157

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Root Cause of Cystic Fibrosis

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-08 ,pp. : 933-944

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epigenetics in Nervous System Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 1, 2013-02 ,pp. : 126-141

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting ENaC as a Molecular Suspect in Cystic Fibrosis

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. : 951-957

Bentham Science Publishers

Access to resources Recommend Favorite